Long QT Syndrome surgery: Difference between revisions
Farima Kahe (talk | contribs) No edit summary |
Farima Kahe (talk | contribs) |
||
| Line 23: | Line 23: | ||
==Indications== | ==Indications== | ||
*Implantable cardioverter-defibrillator is not the first-line treatment option for patients with long QT syndrome. Surgery is usually reserved for patients with either:<ref name="pmid12741701">{{cite journal |vauthors=Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M |title=Implantable cardioverter defibrillator in high-risk long QT syndrome patients |journal=J. Cardiovasc. Electrophysiol. |volume=14 |issue=4 |pages=337–41 |date=April 2003 |pmid=12741701 |doi=10.1046/j.1540-8167.2003.02545.x |url=}}</ref><ref name="pmid18549912">{{cite journal |vauthors=Goldenberg I, Moss AJ |title=Long QT syndrome |journal=J. Am. Coll. Cardiol. |volume=51 |issue=24 |pages=2291–300 |date=June 2008 |pmid=18549912 |doi=10.1016/j.jacc.2008.02.068 |url=}}</ref> | |||
**Strong family history of sudden cardiac death | |||
**High-risk patients with Jervell and Lang-Nielsen (JLN) syndrome | |||
* | *Left cervicothoracic stellectomy is another antiadrenergic therapeutic measure used in high-risk patients with long QT syndrome (LQTS), especially in those with recurrent cardiac events despite beta-blocker therapy. | ||
==Surgery== | ==Surgery== | ||
Revision as of 16:04, 14 April 2020
|
Long QT Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Long QT Syndrome surgery On the Web |
|
American Roentgen Ray Society Images of Long QT Syndrome surgery |
|
Risk calculators and risk factors for Long QT Syndrome surgery |
Overview
Surgical intervention is not recommended for the management of [disease name].
OR
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
Surgery is the mainstay of treatment for [disease or malignancy].
Indications
- Implantable cardioverter-defibrillator is not the first-line treatment option for patients with long QT syndrome. Surgery is usually reserved for patients with either:[1][2]
- Strong family history of sudden cardiac death
- High-risk patients with Jervell and Lang-Nielsen (JLN) syndrome
- Left cervicothoracic stellectomy is another antiadrenergic therapeutic measure used in high-risk patients with long QT syndrome (LQTS), especially in those with recurrent cardiac events despite beta-blocker therapy.
Surgery
- The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
- Surgery is the mainstay of treatment for [disease or malignancy].
Contraindications
References
- ↑ Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M (April 2003). "Implantable cardioverter defibrillator in high-risk long QT syndrome patients". J. Cardiovasc. Electrophysiol. 14 (4): 337–41. doi:10.1046/j.1540-8167.2003.02545.x. PMID 12741701.
- ↑ Goldenberg I, Moss AJ (June 2008). "Long QT syndrome". J. Am. Coll. Cardiol. 51 (24): 2291–300. doi:10.1016/j.jacc.2008.02.068. PMID 18549912.